Advertisement
CPIX vs LFCR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPIX is a Buy and LFCR is a Hold.
Momentum Indicator for CPIX turns positive, indicating new upward trend
CPIX saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 111 similar instances where the indicator turned positive. In 94 of the 111 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 64 cases where CPIX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for CPIX just turned positive on October 20, 2026. Looking at past instances where CPIX's MACD turned positive, the stock continued to rise in 45 of 57 cases over the following month. The odds of a continued upward trend are 79%.
CPIX moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +21.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPIX advanced for three days, in 178 of 215 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Bearish Trend Analysis
The 10-day RSI Indicator for CPIX moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 25 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The 10-day moving average for CPIX crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
CPIX broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CPIX entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. CPIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.020) is normal, around the industry mean (11.138). P/E Ratio (-11.192) is within average values for comparable stocks, (-7.600). CPIX's Projected Growth (PEG Ratio) (17.640) is very high in comparison to the industry average of (2.152). CPIX's Dividend Yield (0.734) is considerably higher than the industry average of (0.038). P/S Ratio (2.362) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
LFCR's RSI Oscillator is remaining in overbought zone for 17 days
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LFCR as a result. In 75 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for LFCR turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 34 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
LFCR broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for LFCR entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
LFCR moved above its 50-day moving average on September 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for LFCR crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +56.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in 207 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. LFCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-7.072) is normal, around the industry mean (11.138). P/E Ratio (-5.016) is within average values for comparable stocks, (-7.600). Projected Growth (PEG Ratio) (2.661) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (1.222) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
CPIX | LFCR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 32 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 53 Fair valued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 36 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 34 | 36 | |
P/E GROWTH RATING 1..100 | 55 | 80 | |
SEASONALITY SCORE 1..100 | 90 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CPIX's Valuation (53) in the Pharmaceuticals Other industry is in the same range as LFCR (61) in the Industrial Specialties industry. This means that CPIX’s stock grew similarly to LFCR’s over the last 12 months.
CPIX's Profit vs Risk Rating (36) in the Pharmaceuticals Other industry is somewhat better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that CPIX’s stock grew somewhat faster than LFCR’s over the last 12 months.
CPIX's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that CPIX’s stock grew similarly to LFCR’s over the last 12 months.
CPIX's Price Growth Rating (34) in the Pharmaceuticals Other industry is in the same range as LFCR (36) in the Industrial Specialties industry. This means that CPIX’s stock grew similarly to LFCR’s over the last 12 months.
CPIX's P/E Growth Rating (55) in the Pharmaceuticals Other industry is in the same range as LFCR (80) in the Industrial Specialties industry. This means that CPIX’s stock grew similarly to LFCR’s over the last 12 months.
| CPIX | LFCR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 2 days ago 87% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 78% |
| Advances ODDS (%) | 2 days ago 83% | 24 days ago 77% |
| Declines ODDS (%) | 4 days ago 81% | 10 days ago 79% |
| BollingerBands ODDS (%) | 2 days ago 86% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 79% | 2 days ago 78% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CPIX’s FA Score shows that 0 FA rating(s) are green while LFCR’s FA Score has 0 green FA rating(s).
- CPIX’s FA Score: 0 green, 5 red.
- LFCR’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CPIX’s TA Score shows that 5 TA indicator(s) are bullish while LFCR’s TA Score has 4 bullish TA indicator(s).
- CPIX’s TA Score: 5 bullish, 5 bearish.
- LFCR’s TA Score: 4 bullish, 6 bearish.
Price Growth
CPIX (@Pharmaceuticals: Generic) experienced а +9.08% price change this week, while LFCR (@Pharmaceuticals: Generic) price change was -0.78% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.
Reported Earning Dates
CPIX is expected to report earnings on Nov 03, 2026.
LFCR is expected to report earnings on Nov 06, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-2.94% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
CPIX and
Correlation & Price change
A.I.dvisor tells us that CPIX and ACB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPIX and ACB's prices will move in lockstep.
| Ticker / NAME | Correlation To CPIX | 1D Price Change % | ||
|---|---|---|---|---|
| CPIX | 100% | +2.64% | ||
| ACB - CPIX | 27% Poorly correlated | -0.25% | ||
| QNTM - CPIX | 26% Poorly correlated | -1.23% | ||
| GLAS - CPIX | 23% Poorly correlated | -0.43% | ||
| YCBD - CPIX | 23% Poorly correlated | -2.17% | ||
| PRGO - CPIX | 22% Poorly correlated | -1.61% | ||
More | ||||
LFCR and
Correlation & Price change
A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.
| Ticker / NAME | Correlation To LFCR | 1D Price Change % | ||
|---|---|---|---|---|
| LFCR | 100% | N/A | ||
| SHPH - LFCR | 31% Poorly correlated | -1.83% | ||
| COLL - LFCR | 28% Poorly correlated | -1.36% | ||
| PAHC - LFCR | 27% Poorly correlated | +1.16% | ||
| TLRY - LFCR | 27% Poorly correlated | -3.63% | ||
| VTRS - LFCR | 25% Poorly correlated | -1.07% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MMID | 27.06 | 0.08 | +0.31% |
| MFS Active Mid Cap ETF (MMID) | |||
| FSCC | 33.75 | 0.04 | +0.12% |
| Federated Hermes MDT Small Cap Core ETF (FSCC) | |||
| SMDX | 25.94 | N/A | N/A |
| Intech S&P Small-Mid Cap Diversified Alpha ETF | |||
| JPIB | 46.83 | -0.02 | -0.04% |
| JPMorgan International Bond Opportunities Fund (JPIB) | |||
| MZZ | 6.39 | -0.06 | -0.88% |
| ProShares UltraShort MidCap400 (MZZ) | |||